Cardiovascular system

Last updated: August 2018

This section gives guidance for the assessment of applicants’ cardiovascular system.

In this section:

General considerations

12-lead ECG interpretation

Hypertension

Cardiovascular risk assessment

Coronary heart disease

Mitral valve disease

Aortic valve disease

Tricuspid and pulmonary valve disease

Valve replacement or repair

Atrial fibrillation (AF) and atrial flutter

Atrial and ventricular premature beats

Sinus node arrest and sinoatrial block

Ventricular pre-excitation

Atrio-ventricular block (AV block)

Left Bundle Branch Block (LBBB)

Right Bundle Branch Block (RBBB)

Left anterior and left posterior hemi-block

QT prolongation

Brugada syndrome

Implantable devices - Pacemaker

Cardiomyopathy

Pericarditis

Aortic aneurysm

Peripheral vascular disease

Venous thrombo-embolism and anticoagulation

Congenital heart disease

Marfan’s syndrome

Use of Warfarin

Use of novel anticoagulants (NOACs)